Literature DB >> 14973278

Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3.

Marten P Smidt1, Simone M Smits, Hans Bouwmeester, Frank P T Hamers, Annemarie J A van der Linden, Anita J C G M Hellemons, Jochen Graw, J Peter H Burbach.   

Abstract

The mesencephalic dopamine (mesDA) system is involved in the control of movement and behavior. The expression of Pitx3 in the brain is restricted to the mesDA system and the gene is induced relatively late, at E11.5, a time when tyrosine hydroxylase (Th) gene expression is initiated. We show here that, in the Pitx3-deficient aphakia (ak) mouse mutant, the mesDA system is malformed. Owing to the developmental failure of mesDA neurons in the lateral field of the midbrain, mesDA neurons are not found in the SNc and the projections to the caudate putamen are selectively lost. However, Pitx3 is expressed in all mesDA neurons in control animals. Therefore, mesDA neurons react specifically to the loss of Pitx3. Defects of motor control where not seen in the ak mice, suggesting that other neuronal systems compensate for the absence of the nigrostriatal pathway. However, an overall lower activity was observed. The results suggest that Pitx3 is specifically required for the formation of the SNc subfield at the onset of dopaminergic neuron differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973278     DOI: 10.1242/dev.01022

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  100 in total

1.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

Review 2.  Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Authors:  Sarah L Maxwell; Meng Li
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

Review 3.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

4.  Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice.

Authors:  Paola Sgadò; Lavinia Albéri; Daniel Gherbassi; Sherri L Galasso; Geert M J Ramakers; Kambiz N Alavian; Marten P Smidt; Richard H Dyck; Horst H Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

5.  Pitx3 promoter directs Cre-recombinase specifically in a human neuroblastoma cell line.

Authors:  Diana L Castillo-Carranza; Humberto Rodríguez-Rocha; Roberto Montes-de-Oca-Luna; Julio Sepúlveda-Saavedra; Héctor R Martínez; Yolanda López-Vidal; Odila Saucedo-Cárdenas
Journal:  Mol Cell Biochem       Date:  2007-11-30       Impact factor: 3.396

6.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.

Authors:  Yunmin Ding; Jacqueline Restrepo; Lisa Won; Dong-Youn Hwang; Kwang-Soo Kim; Un Jung Kang
Journal:  Neurobiol Dis       Date:  2007-04-10       Impact factor: 5.996

7.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 8.  Induced neuronal reprogramming.

Authors:  Cheen Euong Ang; Marius Wernig
Journal:  J Comp Neurol       Date:  2014-05-21       Impact factor: 3.215

9.  Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.

Authors:  Eva Hedlund; Jan Pruszak; Thomas Lardaro; Wesley Ludwig; Angel Viñuela; Kwang-Soo Kim; Ole Isacson
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

10.  Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons.

Authors:  Dong-Youn Hwang; Sunghoi Hong; Joo-Won Jeong; Sangdun Choi; Hansoo Kim; Jangwoo Kim; Kwang-Soo Kim
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.